EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study

Nicholas J Ashton, Ashvini Keshavan iD, Wagner S Brum, Ulf Andreasson, Burak Arslan, Mathias Droescher, Stefan Barghorn, Jeroen Vanbrabant, Charlotte Lambrechts, Maxime Van Loo, Erik Stoops, Shweta Iyengar und 32 weitere

Alzheimer's & Dementia · 2025-02 · 21 (2)

DOI: 10.1002/alz.14508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.02.2025. Verfasst von Nicholas J Ashton und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal…. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Biomarkers. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Brain Foundation, Regionalt Forskningsstöd, Swedish federal government under the ALF agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The Alzheimer's Association Global Biomarker Standardization Consortium conducted a blinded case–control study to learn which phosphorylated tau (p‐tau) assays provide the largest fold‐changes in Alzheimer's disease (AD) versus non‐AD and show commutability in measuring patient samples and candidate certified reference materials (CRMs). METHODS Thirty‐three different p‐tau assays measured paired plasma and cerebrospinal fluid (CSF) from 40 participants (25 with “AD pathology” and 15 with “non‐AD pathology” by CSF amyloid beta [Aβ]42/Aβ40 and p‐tau181 criteria). Four CRMs were assessed. RESULTS Plasma p‐tau217 demonstrated higher fold‐changes between AD and non‐AD than other p‐tau epitopes. Fujirebio LUMIPULSE G, UGOT IPMS, and Lilly MSD p‐tau217 provided the highest fold‐changes. Plasma p‐tau217 showed the strongest correlations between plasma assays (rho = 0.81–0.97). The CRMs were not commutable across assays. DISCUSSION Plasma p‐tau217 showed larger fold‐changes and better accuracy for detecting AD pathology in symptomatic individuals, with greater cross‐platform agreement than other p‐tau variants. Further work is needed to develop suitable CRMs facilitating cross‐assay standardization. Highlights Paired plasma and cerebrospinal fluid (CSF) samples from twenty‐five Alzheimer's disease (AD) and 15 non‐AD patients were measured blind. Thirty‐three plasma assays were compared, for phosphorylated tau‐181 (p‐tau181), 205, 212, 217 and 231. Plasma p‐tau217 consistently had the highest fold‐change and was best correlated between assays. Plasma‐CSF correlations were weak to moderate. There was lack of commutability for four candidate reference materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseBiomarkersHumansFemaleMalePhosphorylationAgedAmyloid beta-PeptidesCase-Control StudiesAged, 80 and overMiddle AgedReference StandardsPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseasecandidate reference materialscerebrospinal fluidcommutabilityimmunoassayphosphorylated tauplasma

Substanzen

tau ProteinsBiomarkersAmyloid beta-PeptidesPeptide FragmentsMAPT protein, human

Autor:innen und Institutionen

  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
  • NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust, London, UK.
  • Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.

ORCID-Profile: Ashvini Keshavan

Förderung

  • Swedish Brain Foundation
  • Regionalt Forskningsstöd
  • Swedish federal government under the ALF agreement
  • Eli Lilly Research
  • Strategic Research Area MultiPark at Lund University
  • Erling-Persson Family Foundation
  • NIA NIH HHS
  • AD Strategic Fund

Zitieren

APA

Ashton, N. J., Keshavan, A., Brum, W. S., Andreasson, U., Arslan, B., Droescher, M., Barghorn, S., Vanbrabant, J., Lambrechts, C., Van Loo, M., Stoops, E., Iyengar, S., Ji, H., Xu, X., Forrest-Hay, A., Zhang, B., Luo, Y., Jeromin, A., Vandijck, M., …, & Zetterberg, H. (2025). The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14508

Vancouver

Ashton NJ, Keshavan A, Brum WS, Andreasson U, Arslan B, Droescher M, et al. The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14508

BibTeX
@article{Ashton2025,
  author = {Ashton, Nicholas J and Keshavan, Ashvini and Brum, Wagner S and Andreasson, Ulf and Arslan, Burak and Droescher, Mathias and Barghorn, Stefan and Vanbrabant, Jeroen and Lambrechts, Charlotte and Van Loo, Maxime and Stoops, Erik and Iyengar, Shweta and Ji, HaYeun and Xu, Xiaomei and Forrest-Hay, Alex and Zhang, Bingqing and Luo, Yuling and Jeromin, Andreas and Vandijck, Manu and Bastard, Nathalie Le and Kolb, Hartmuth and Triana-Baltzer, Gallen and Bali, Divya and Janelidze, Shorena and Yang, Shieh-Yueh and Demos, Catherine and Romero, Daniel and Sigal, George and Wohlstadter, Jacob and Malyavantham, Kishore and Khare, Meenakshi and Jethwa, Alexander and Stoeckl, Laura and Gobom, Johan and Kac, Przemysław R and Gonzalez-Ortiz, Fernando and Montoliu-Gaya, Laia and Hansson, Oskar and Rissman, Robert A and Carrillo, Maria C and Shaw, Leslie M and Blennow, Kaj and Schott, Jonathan M and Zetterberg, Henrik},
  title = {The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {2},
  doi = {10.1002/alz.14508}
}
Kostenlos starten →